Showing results (271-280 of 285) with videos related to

Sort By:
Pageof 29
Molecular Endocrinology (Baltimore, Md.)|June 1, 1988
Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significanceS E Bates, N E Davidson, E M Valverius, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 1992
Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer InstituteA S Lichter, M E Lippman, D N Danforth, et al.
Clinical & Experimental Metastasis|May 1, 1994
Oncogene-induced basement membrane invasiveness in human mammary epithelial cellsE W Thompson, J Torri, M Sabol, et al.
Bone Marrow Transplantation|January 31, 1998
Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer: investigation of dose level with clinical correlatesK R Meehan, U N Verma, R Cahill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1986
Complete axillary lymph node dissection for stage I-II carcinoma of the breastD N Danforth, P A Findlay, H D McDonald, et al.
Cancer Research|April 1, 1980
Clinical correlations of steroid receptors and male breast cancerR B Everson, M E Lippman, E B Thompson, et al.
The Journal of Biological Chemistry|March 20, 1999
Cripto-1 indirectly stimulates the tyrosine phosphorylation of erb B-4 through a novel receptorC Bianco, S Kannan, M De Santis, et al.
Breast Cancer Research and Treatment|November 27, 2013
CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-upT Dan, S M Hewitt, N Ohri, et al.
International Journal of Cancer|June 9, 1999
Inhibition of angiogenesis and breast cancer xenograft tumor growth by VEGI, a novel cytokine of the TNF superfamilyY Zhai, J Yu, L Iruela-Arispe, et al.
Journal of the National Cancer Institute|October 6, 2000
Immunoconjugates of geldanamycin and anti-HER2 monoclonal antibodies: antiproliferative activity on human breast carcinoma cell linesR Mandler, C Wu, E A Sausville, et al.
Pageof 29